Transluminal Technologies

About:

Transluminal Technologies develops intellectual property related to interventional cardiovascular medical devices.

Description:

Transluminal Technologies develops intellectual property related to interventional cardiovascular medical devices. Its vascular closure device offers a way of reaching mechanical vascular closure that seals the arteriotomy to achieve immediate hemostasis and then absorbs over a period of days as natural healing occurs that enable patients to quickly recover after a cardiovascular surgery.

Total Funding Amount:

$3M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Syracuse, New York, United States

Founded Date:

2008-01-01

Founders:

Stephen M. Green

Number of Employees:

11-50

Last Funding Date:

2015-05-21

IPO Status:

Private

Industries: